SUZHOU, China, Sept. 20, 2024 /PRNewswire/ — CD (Suzhou) Biopharma has received clearance from the U.S. Food and Drug Administration (FDA) for its Investigational New Drug (IND) application of CD-001, entering a Phase I first-in-human trial. […]
#Rosal Top Picks
Recent Posts
- B2B company strengthens management to extend services
- As one of the world’s leading food and beverage
- Unused Updates for LUMIX Lab and LUMIX Wave Apps, in
- CHICAGO, Oct. 16, 2025 /PRNewswire/ — For over
- HUNTERSVILLE, N.C. , 16 de octubre de
